Subscribe
shutterstock_96721225_steve_heap
Steve Heap / Shutterstock.com
12 March 2020AmericasRory O'Neill

Texas uni wants Supreme Court to settle state sovereignty rules

The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.
Biotechnology
Texas uni loses bid to shield cancer vaccine patents from IPRs
18 February 2021   The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.
Americas
Texas court awards $41m to US biotech
21 July 2022   Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Texas court awards $41m to US biotech
21 July 2022   Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.
Biotechnology
Texas uni loses bid to shield cancer vaccine patents from IPRs
18 February 2021   The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.
Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.

More on this story

Americas
Texas court awards $41m to US biotech
21 July 2022   Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.
Biotechnology
Texas uni loses bid to shield cancer vaccine patents from IPRs
18 February 2021   The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.
Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York